- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00808925
The Impact of Heat Acclimation on Pro- and Anti- Inflammatory Cytokine Response
December 18, 2013 updated by: Prof. Yoram Epstein
There is growing evidence to conclude that part of the cascade leading to heatstroke is related to an inflammatory reaction triggered by the heat stress.
The reduced ability to sustain heat stress - "heat intolerance" is also attributed to over-expression of inflammatory cytokines.
Acclimation to heat improves human sustainability to heat and is a leading protective factor against heat stroke.
The investigators hypothesize that the lower stress encountered during the process of acclimation to heat will be reflected by an over-ride in the expression of anti-inflammatory over the pro-inflammatory cytokines.
This, in turn will attenuate the pathological cascade leading to heat stroke.
Study Overview
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tel Hashomer, Israel, 52621
- Heller Institute of Medical Reachearch, Sheba Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- age:18-25
- medically screened (healthy)
Exclusion Criteria:
- BMI over 22 kg/m2
- systolic blood pressure over 120 mmHg
- any febrile illness during the last week preceding the study
- any skin disease
- diabetes
- any heart conditions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: research arm
|
Dressed in shorts and tennis shoes the subjects will be exposed to exercise-heat stress for 12 consecutive days (excluding Saturday).
Daily exposure will last 120 min, under the controlled environmental conditions of 40oC and 40% relative humidity.
The exercise will consist of walking on a treadmill at a pace of 5km/h and 2% incline.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Investigating the variability in the levels of different cytokine and the kinetics in cytokine levels during the process of acclimation to heat.
Time Frame: 12 days
|
12 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Daniel S Moran, PhD, Institute of Military Physiology, IDF Medical Corps
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2009
Primary Completion (Actual)
April 1, 2013
Study Completion (Actual)
July 1, 2013
Study Registration Dates
First Submitted
December 15, 2008
First Submitted That Met QC Criteria
December 15, 2008
First Posted (Estimate)
December 16, 2008
Study Record Updates
Last Update Posted (Estimate)
December 19, 2013
Last Update Submitted That Met QC Criteria
December 18, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SHEBA-08-5524-YE-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.